Neoplasm Risk in Rheumatic Diseases Has No Correlation With Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs Usage—A Population-Based Nested Case–Control Study

por Cai, Shaozhe, Perng, Wuu-Tsun, Huang, Jing Y., Chiou, Jeng-Yuan, Dong, Lingli, Wei, James C.
Publicado 2020

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

por van der Heijde, Désirée, Deodhar, Atul, Wei, James C, Drescher, Edit, Fleishaker, Dona, Hendrikx, Thijs, Li, David, Menon, Sujatha, Kanik, Keith S
Publicado 2017

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes

por Yen, Fu‐Shun, Yang, Yu‐Cih, Hwu, Chii‐Min, Wei, James C.‐C., Huang, Yi‐Hsiang, Hou, Ming‐Chih, Hsu, Chih‐Cheng
Publicado 2020